Board Member
Pacira BioSciences, Inc. (PCRX)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
Frank Lee is recorded as CEO and Board Member at Pacira BioSciences, Inc. (PCRX). Pacira BioSciences, Inc. reported in an 8-K filed December 21, 2023 that Frank Lee was appointed member of the Board, effective January 2, 2024. Pacira BioSciences, Inc. reported in an 8-K filed December 21, 2023 that Frank Lee was appointed Chief Executive Officer, effective January 2, 2024. The proxy statement of Pacira BioSciences, Inc. reports total compensation of $15,944,347 for Frank Lee in fiscal 2024, including a base salary of $896,539. Frank Lee has spoken on 11 earnings calls and 3 other investor events across 1 company, most recently for Pacira BioSciences, Inc. on August 4, 2026.
“On December 20, 2023, the Board appointed Frank Lee as Chief Executive Officer of the Company and as a member of the Board, effective January 2, 2024.”
“On December 20, 2023, the Board appointed Frank Lee as Chief Executive Officer of the Company and as a member of the Board, effective January 2, 2024.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Recorded current and former roles; source labels appear when available.
2024-01-02–present
Recorded roles and call appearances connecting this person to public companies.
CEO, Board Member
2024-01-02–present
Other people whose current roles at this company are on record from its filings.
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2024 | Pacira BioSciences, Inc. (PCRX) | Chief Executive Officer | $896,539 | $15,944,347 |
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.
